Published: Sat, April 27, 2019
Medicine | By Brett Sutton

Eight counties targeted for piloting new malaria vaccine

Eight counties targeted for piloting new malaria vaccine

The pilot programme is a collaboration between the United Nations, ministries of health in Ghana, Kenya and Malawi and national and worldwide partners, including non-profit organisation PATH, and vaccine developer and manufacturer GSK, which donated 10 million doses for the pilot. In 2017, children younger than 5 made up 61%, or 266,000, of reported deaths. Malaria kills as many as 250,000 African children under the age of five every year.

Thirty years in the making, Mosquirix is the first, and to date, the only, vaccine that has demonstrated it can significantly reduce malaria in children.

"We urge the people not just to collect these nets but use them".

Matshidiso Moeti, the World Health Organization regional director for Africa, in the World Health Organization statement, echoed Laufer's comments, adding that the disease is a constant threat in African communities where "the poorest children suffer the most and are at highest risk of death".

The procession started from Directorate of Health Services Jammu and covered prominent places of Jammu urban area. People just look at malaria as ordinary because it has been with us for a very long time and so they don't take it serious.

Speaking at an event to mark World Malaria Day on Thursday, 25 April 2019, Mrs Akufo-Addo said Ghana has scaled up existing interventions and is on track to pilot the malaria vaccine.

The vaccine trial will be done in four dose schedule: "at five, six, seven and 22 months", explains Kayange.

Malawi's mothers like Fanny Kaphamtengo are excited about the vaccine's potential.

"When waste are properly disposed and drainages are free of waste and without any blockage, malaria and other diseases will be prevented", he said.

Mobile telecommunication giant, MTN through its Foundation, has marked this year's World Malaria Day celebration with a screening and treatment of the disease among residents of Somanya and its environs in the Eastern Region.

To complement the RTS, S vaccine, which has been shown to be subject to strain-specific immunity, YSPH Assistant Professor Amy Bei, Ph.D., is working on the discovery of novel malaria vaccine candidates using diversity from the field as a starting point.

"Together, we have cut malaria mortality by half in sub-Saharan Africa and saved over seven million lives since 2000".

While celebrating the launch of the vaccine, the World Health Organization also reminds that it's a complementary malaria control tool added to the core package of WHO-recommended measures for malaria prevention, including the routine use of insecticide-treated bed nets, indoor spraying with insecticides, and the timely use of malaria testing and treatment. The WHO wants the vaccine used alongside other preventive measures such as treated bed nets, insecticides, repellents and antimalarial drugs.

Like this: